You are here: Industry Insights > CSL

News List

CSL to acquire Switzerland’s Vifor Pharma for $11.7bn Pharmaceutical-Technology
December 16, 2021
CSL has signed a definitive agreement for the acquisition of all publicly held stakes of Switzerland-based Vifor Pharma in a deal worth $11.7bn (A$16.4bn) in cash.
Startups join CSL, Moderna in local mRNA vaccine manufacturing push firstwordpharma
July 22, 2021
Australian biotech startups and small businesses have joined pharmaceutical majors like CSL in pitching to the federal government for a role in making mRNA products in the country, reported The Age.
New data boosts AstraZeneca COVID-19 vaccine in US expresspharma
March 23, 2021
The trials in the US, Chile and Peru showed the vaccine was 79 per cent effective at preventing symptomatic COVID-19.
Australia to initiate manufacturing of vaccine candidate for Covid-19 pharmaceutical-technology
November 10, 2020
Australia is planning to commence the manufacturing of Covid-19 vaccine candidate, AZD1222, at biotech firm CSL’s advanced manufacturing facility in Broadmeadows, Victoria.
Australia’s star vaccine maker not immune to virus anxiety: Analysis expresspharma
October 29, 2020
A promise to supply Australia's 25 million people with a coronavirus vaccine, if one becomes available, has boosted CSL's profile.
Australia enters $1.2bn Covid-19 vaccine supply agreement pharmaceutical-technology
September 17, 2020
The Government of Australia has signed a supply and production agreement valued at A$1.7bn ($1.2bn) to potentially offer a free Covid-19 vaccine to its citizens next year.
UQ’s Covid-19 vaccine shows effectiveness in preclinical studies pharmaceutical-technology
August 28, 2020
The University of Queensland (UQ) in Australia has reported positive data from preclinical tests of its Covid-19 vaccine candidate conducted by Viroclinics-DDL in the Netherlands.
UQ, CEPI and CSL Partner on Development and Manufacture of COVID-19 Vax Candidate contractpharma
June 09, 2020
CSL appointed manufacturer for University of Queensland's "molecular clamp" enabled COVID-19 vaccine candidate.
CSL teams up with CEPI and UQ for Covid-19 vaccine pharmaceutical-technology
June 08, 2020
Australia-based biotechnology company CSL has partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Queensland (UQ) to advance the university’s Covid-19 vaccine.
Australia’s CSL says to help fund, make vaccine candidate if it proves successful expresspharma
June 08, 2020
Early pre-clinical results for the vaccine candidate have shown it produced high levels of antibodies that can neutralise the virus, CSL said.

Previous page 1 2 Next page